Westlaanapotheek
0859.788.697 · rovalta.com · 25/09/2026
Westlaanapotheek
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOWestlaanapotheek is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Roeselare. It employs on average 6,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0859.788.697
- Incorporation
- 25/07/2003
- Legal form
- Private limited company
- Registered office
- Westlaan 138
8800 Roeselare · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
- Average workforce
- 6,2 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 20 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 659,6 k € | -0.8% | 664,8 k € | +5.9% | 627,6 k € | +10.1% | 570,3 k € | +36.6% | 417,5 k € |
| EBITDA | 293,3 k € | -12.7% | 335,9 k € | +19.3% | 281,5 k € | +1.2% | 278,2 k € | +152% | 110,2 k € |
| Operating result | 222,2 k € | -16.7% | 266,6 k € | +32.3% | 201,5 k € | +4.8% | 192,3 k € | +606% | 27,2 k € |
| Net result | 214,1 k € | -16.9% | 257,7 k € | +35.4% | 190,4 k € | +4.9% | 181,4 k € | +1145% | 14,6 k € |
| Balance sheet | |||||||||
| Equity | 476,1 k € | +1.3% | 470 k € | +0.0% | 469,8 k € | +2.1% | 459,9 k € | +0.3% | 458,5 k € |
| Total assets | 2 M € | +4.4% | 2 M € | +7.3% | 1,8 M € | +2.5% | 1,8 M € | +5.1% | 1,7 M € |
| Cash | 770,6 k € | -5.5% | 815,2 k € | +43.1% | 569,7 k € | -8.5% | 622,7 k € | +22.4% | 508,6 k € |
| Debts | 1,6 M € | +5.4% | 1,5 M € | +9.6% | 1,3 M € | +2.9% | 1,3 M € | +7.0% | 1,2 M € |
| Other | |||||||||
| Workforce | 6,2 ETP | +10.7% | 5,6 ETP | +5.7% | 5,3 ETP | -10.2% | 5,9 ETP | 0.0% | 5,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/2025Other companies at this address
Westlaan 138 8800 Roeselare| Company | CBE no. |
|---|---|
CORTEXCO● Active | 0898.426.272 |
DERTIEN-ACHT● Active | 0883.202.420 |
GROEP WESTLAAN BTW EENHEID● Active | 1013.092.249 |
PHARMA DMS● Active | 0821.606.232 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2026 | 18/04/2025 | 22/04/2024 | 11/04/2023 | 19/04/2022 | 22/04/2021 |
| General meeting | 31/03/2026 | 22/03/2025 | 23/03/2024 | 18/03/2023 | 19/03/2022 | 27/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 31/03/2026 | 30/04/2026 | Dutch | |
| Abridged model | 30/09/2024 | 22/03/2025 | 18/04/2025 | Dutch | |
| Abridged model | 30/09/2023 | 23/03/2024 | 22/04/2024 | Dutch | |
| Abridged model | 30/09/2022 | 18/03/2023 | 11/04/2023 | Dutch | |
| Abridged model | 30/09/2021 | 19/03/2022 | 19/04/2022 | Dutch | |
| Abridged model | 30/09/2020 | 27/03/2021 | 22/04/2021 | Dutch | |
| Abridged model | 30/09/2019 | 21/03/2020 | 14/04/2020 | Dutch | |
| Abridged model | 30/09/2018 | 23/03/2019 | 16/04/2019 | Dutch | |
| Abridged model | 30/09/2017 | 31/03/2018 | 27/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 18/03/2017 | 12/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 19/03/2016 | 23/03/2016 | Dutch | |
| Abridged model | 30/09/2014 | 21/03/2015 | 23/03/2015 | Dutch | |
| Abridged model | 30/09/2013 | 29/03/2014 | 22/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 23/03/2013 | 11/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 24/03/2012 | 11/04/2012 | Dutch | |
| Abridged model | 30/09/2010 | 19/03/2011 | 29/03/2011 | Dutch | |
| Abridged model | 30/09/2009 | 31/03/2010 | 29/04/2010 | Dutch | |
| Abridged model | 30/09/2008 | 28/03/2009 | 21/04/2009 | Dutch | |
| Abridged model | 30/09/2007 | 29/03/2008 | 28/04/2008 | Dutch | |
| Abridged model | 30/09/2006 | 24/03/2007 | 29/03/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/2025Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates14/05/2010ONTSLAGEN - BENOEMINGEN
- Mandates04/02/2010BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates05/03/2007ONTSLAGEN - BENOEMINGEN
- Other04/08/2003RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025214,1 k €↓
- 2024Annual accounts 2024257,7 k €↑
- 2023Annual accounts 2023190,4 k €↑
- 2022Annual accounts 2022181,4 k €↑
- 2021Annual accounts 202114,6 k €↓
- 2018Annual accounts 2018112,2 k €↓
- 2017Annual accounts 2017135,3 k €↑
- 2016Annual accounts 2016100 k €↑
- 2015Annual accounts 201544,1 k €↓
- 2014Annual accounts 2014104,7 k €↑
- 2013Annual accounts 201377,3 k €↑
- 2012Annual accounts 2012-504 €↓
- 2011Annual accounts 201139,3 k €↑
- 2010Annual accounts 201020,5 k €↓
- 2009Annual accounts 200967,9 k €↑
- 2008Annual accounts 200833,4 k €↑
- 2007Annual accounts 2007-7,8 k €
- 25/07/2003IncorporationPrivate limited company